In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Working Group on Cardiovascular Pharmacotherapy


The Working Group on Cardiovascular Pharmacotherapy of the ESC is actively involved with all aspects of cardiovascular pharmacology, from basic pharmacology over clinical trials to clinical pharmacology.

Our Working Group was featured in the November 2023 edition of CardioPulse in the European Heart Journal. Read about the evolution of our Working Group and our endeavours to inform and educate trainees and established practitioners working in the field.


Aims and Activities

Aims

  • To promote and organise research in the field of cardiovascular pharmacology and drug therapy
  • To design and coordinate scientific research in its specialty
  • To be involved in task forces of the European Society of Cardiology related to cardiovascular pharmacology
  • To increase the number of Working Group members

Activities

  • To start up and strengthen the new journal of the Working Group, entitled European Heart Journal-Cardiovascular Pharmacotherapy. The journal will come out with 4 issues during 2015 aiming at increasing that number up to 12 issues a year within 5-6 years. An aim with the journal is to become the strongest scientific journal within cardiovascular pharmacology
  • To organise yearly scientific meeting of the Working Group with focus on cardiovascular pharmacology
  • To participate in the production of ESC Clinical Practice Guidelines
  • To publish position papers within the area of the Working Group
  • To contribute to the organisation and preparation of the Annual Congress of the ESC
  • To participate and support other scientific meetings and symposia
  • To organise teaching workshops and other types of education on topics related to cardiovascular pharmacology and drug therapy
  • To hold regular meetings of the nucleus of the Working Group

Nucleus 2022-2024

Chairperson

Prof. Juan Carlos Kaski, FESC
St George's, University of London
Molecular & Clinical Sciences Research Inst
SW17 ORE London
United Kingdom of Great Britain and Northern Ireland
email address

Chairperson-Elect

Prof. Dobromir Dobrev, FESC
University Duisburg-Essen
Institute of Pharmacology
Hufelandstrasse 55
DE-45122 Essen
Germany
email address

Past-Chairperson

Assoc. Prof. Alexander Niessner
Medical University Of Vienna
Dept. Int. Med. Ii, Division Of Cardiology
Waehringer Guertel 18-20
AT-1090 Vienna
Austria 
email address

Treasurer

Prof. Claudio Ceconi, FESC
Italy
email address

Secretary 

Dr. Anne Grete Semb, FESC
Norway
email address

Communication coordinator

Assoc. Prof. Bianca Rocca, FESC
Italy
email address

Ordinary Nucleus members

Prof. Claudio Borghi, FESC
Italy
email address

Prof. Elisabetta Cerbai, FESC
Italy
email address

Prof. Peter Ferdinandy
Hungary
email address

Assoc. Prof. Erik Lerkevang Grove, FESC
Denmark
email address

Prof. Samuel Sossalla
Germany
email address

Dr. Patrick Sulzgruber, FESC
EuroCVP & Working Group representative in ESC Young Committee
Austria
email address

Non-voting Nucleus members

Prof. Gheorghe Andrei Dan, FESC
Romania
email address

Prof. Heinz Drexel, FESC
Austria
email address

Dr. Emma Magavern
United Kingdom of Great Britain and Northern Ireland
email address

Assoc. Prof. Gianluigi Savarese, FESC
Sweden
email address

Prof. Juan Luis Tamargo, FESC
Spain
email address